The Power of Data in the Psychedelic Movement

The psychedelic movement is gaining momentum around the world, but its future depends on one essential ingredient: data. Without reliable, large-scale information on outcomes, safety, and integration, the field risks moving too slowly — or being guided by anecdotes rather than evidence.

Clinical trials have shown remarkable promise for psilocybin therapy, MDMA-assisted treatment, and other plant-based medicines, yet these studies often involve fewer than 10,000 participants globally. For a therapy with the potential to impact millions, that’s not enough.

By collecting real-world psychedelic therapy outcomes — across diverse communities, settings, and protocols — we can:

• Empower practitioners with insights to refine care.
  

• Give researchers the evidence needed to advance psychedelic science.
  

• Provide policymakers with the facts required to shape safe, effective access.

  At Psychedelic Data Society – U.S., we believe every healing story matters. When combined, those stories create the foundation for a future where safe psychedelic therapy is available to all who need it.

👉 Join us in building the evidence base that will move this movement forward.